Primary immune thrombocytopenia, prolonged use of corticosteroids compromises quality of life

Primary immune thrombocytopenia, prolonged use of corticosteroids compromises quality of life

Spread the love

Primary immune thrombocytopenia, prolonged use of corticosteroids compromises quality of life

During the event ‘Primary immune thrombocytopenia: changing the approach to change life ‘, promoted by Inrete with the non-conditioning contribution of Novartis, the study’ Analysis of the epidemiology and drug use of patients with primary immune thrombocytopenia in Italian contexts’ was presented, conducted by CliCon Srl. The round table also offered the opportunity to illustrate the results of the international studio ‘iWISh’ which photographs the negative impact on patients’ quality of life, also linked to prolonged therapy with corticosteroids.